Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07181876 · ClinicalTrials.gov registry record
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
A clinical trial of Inguinal Hernia Repair, sponsored by Distalmotion.
- Recruiting
- Registry status
- 140
- Enrollment target
- 2
- Study locations
NCT07181876: Recruiting study of Inguinal Hernia Repair, sponsored by Distalmotion.
NCT07181876 is a study of Inguinal Hernia Repair that is actively recruiting participants, run by Distalmotion. The registered enrollment target is 140 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07181876, a study of Inguinal Hernia Repair, is actively recruiting participants, sponsored by Distalmotion.
- RECRUITING
- Registry status
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.
Primary Outcome
Occurrence of Clavien-Dindo grades III-V adverse events
Conditions Studied
Interventions
- DEVICE inguinal hernia repair
Study Locations (2)
New York
- Northtowns Ambulatory Surgical Center (NASC) - Buffalo
Texas
- Memorial Hermann-Texas Medical Center - UT Health Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-11-26 |
| Est. Completion | 2029-12 |
What NCT07181876 shows while recruiting
NCT07181876 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Inguinal Hernia Repair appearing as the primary indexed condition, and to 1 intervention - of which inguinal hernia repair is the first listed.
NCT07181876 reports a single indexed study location in New York, Texas.
Frequently Asked Questions
What is clinical trial NCT07181876 about?
NCT07181876 is a clinical study titled "Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System". The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.
What is the current status of trial NCT07181876?
This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2025-11-26. Estimated completion is 2029-12.
What conditions does trial NCT07181876 study?
This clinical trial studies the following conditions: Inguinal Hernia Repair.
What interventions are being tested in trial NCT07181876?
The interventions under investigation include: inguinal hernia repair (DEVICE).
Who is sponsoring clinical trial NCT07181876?
This trial is sponsored by Distalmotion, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07181876 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inguinal Hernia Repair
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI